{{Enzyme
|celltype=Low cell type specificity
|celltype_source=HPA
|celltype_source_key=ENSG00000085998
|description=Attach beta 2 GlcNAc to Man.
|disease=Congenital muscular dystrophy with cerebellar involvement;Muscle-eye-brain disease;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3;Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3;Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3;Retinitis pigmentosa;Retinitis pigmentosa 76;Walker-Warburg syndrome
|disease_source=HPO
|disease_source_key=55624
|genename=POMGNT1
|ortholog=Pomgnt1
|phenotype=Abnormal brain morphology;Abnormal brainstem morphology;Abnormal cerebellar vermis morphology;Abnormal cerebellum morphology;Abnormal circulating aldolase concentration;Abnormal circulating creatine kinase concentration;Abnormal circulating lactate dehydrogenase concentration;Abnormal cortical gyration;Abnormal electroretinogram;Abnormal optic nerve morphology;Abnormal pyramidal sign;Abnormal retinal vascular morphology;Abnormal testis morphology;Abnormality iris morphology;Abnormality of movement;Abnormality of neuronal migration;Abnormality of retinal pigmentation;Abnormality of speech or vocalization;Abnormality of the voice;Absent septum pellucidum;Agenesis of corpus callosum;Anophthalmia;Aplasia/Hypoplasia involving the skeletal musculature;Aplasia/Hypoplasia of the cerebellum;Aplasia/Hypoplasia of the corpus callosum;Areflexia;Attenuation of retinal blood vessels;Autosomal recessive inheritance;Bifid uvula;Blindness;Bone spicule pigmentation of the retina;Buphthalmos;Calf muscle hypertrophy;Calf muscle pseudohypertrophy;Cardiomyopathy;Cataract;Cerebellar cyst;Cerebellar dysplasia;Cerebellar hypoplasia;Chorioretinal dysplasia;Cleft palate;Clonus;Cognitive impairment;Coloboma;Conductive hearing impairment;Congenital muscular dystrophy;Congenital onset;Constriction of peripheral visual field;Corneal opacity;Cryptorchidism;Cystoid macular edema;Dandy-Walker malformation;Decreased light- and dark-adapted electroretinogram amplitude;Decreased thalamic volume;Difficulty climbing stairs;Diffuse white matter abnormalities;Dilated fourth ventricle;EEG abnormality;EMG abnormality;Elevated circulating creatine kinase concentration;Enlarged flash visual evoked potentials;Everted lower lip vermilion;Fatigue;Fusion of the cerebellar hemispheres;Gait disturbance;Generalized hypotonia;Generalized muscle weakness;Glaucoma;Global developmental delay;Gowers sign;Gray matter heterotopia;Hemiplegia/hemiparesis;High myopia;Holoprosencephaly;Hydrocephalus;Hyperautofluorescent macular lesion;Hyperinsulinemia;Hyperlordosis;Hyperreflexia;Hypertonia;Hypoglycosylation of alpha-dystroglycan;Hypogonadism;Hypoplasia of penis;Hypoplasia of the brainstem;Hypoplasia of the pons;Hypoplasia of the retina;Hyporeflexia;Hypotonia;Increased endomysial connective tissue;Increased variability in muscle fiber diameter;Intellectual disability;Intellectual disability, mild;Intellectual disability, profound;Intellectual disability, severe;Iris coloboma;Juvenile onset;Keratoconus;Lissencephaly;Low-set ears;Lumbar hyperlordosis;Macrocephaly;Macroglossia;Macrogyria;Malar flattening;Megalocornea;Meningocele;Metatarsus valgus;Microcephaly;Microcornea;Micrognathia;Microphthalmia;Midface retrusion;Motor delay;Muscle weakness;Muscular dystrophy;Myoclonus;Myopathy;Myopia;Nyctalopia;Nystagmus;Obesity;Occipital encephalocele;Olivopontocerebellar hypoplasia;Opacification of the corneal stroma;Ophthalmoplegia;Optic atrophy;Optic disc pallor;Optic nerve hypoplasia;Pachygyria;Pallor;Peripapillary atrophy;Peripheral visual field loss;Photophobia;Photopsia;Polymicrogyria;Posterior subcapsular cataract;Posteriorly rotated ears;Progressive;Progressive night blindness;Protruding ear;Proximal muscle weakness;Reduced muscle fiber alpha dystroglycan;Reduced visual acuity;Retinal atrophy;Retinal degeneration;Retinal detachment;Retinal dysplasia;Retinal dystrophy;Retinal thinning;Seizure;Sensorineural hearing impairment;Severe global developmental delay;Severe muscular hypotonia;Short nasal bridge;Skeletal muscle atrophy;Skeletal muscle hypertrophy;Spasticity;Specific learning disability;Strabismus;Submucous cleft hard palate;Type II diabetes mellitus;Type II lissencephaly;Uncontrolled eye movements;Undetectable electroretinogram;Ventriculomegaly;Visual impairment
|phenotype_source=HPO
|phenotype_source_key=55624
|species=Human
|tissue=Low tissue specificity
|tissue_source=HPA
|tissue_source_key=ENSG00000085998
|uniprot=Q8WZA1
}}
